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ABSTRACT 
 Sensor based motion analysis is employed to assess frequency, severity and duration of 
Rett syndrome hand stereotypies as well as soft tissue palpation of an arteriovenous fistula. The 
only prior quantification of Rett symptoms have been visually in a clinical setting; defining 
palpation skill is largely unprecedented aside from breast tissue examination. We evaluate 
various sensors used to track motion, measure electromyography, galvanic skin response, and 
heart rate.  The Leap motion controller is evaluated for the viability of tracking hand palpation. 
Verification tests are performed for determining the feasibility, accuracy, and precision of each 
sensor. A static phantom was defined as the two endpoints of each of the six fistulas within the 
palpation simulator and the accuracy of the Leap Motion was <0.9 cm. The 9 DOF motion 
sensor, EMG sensor, and heart rate sensor all pass their respective verification tests.  The 
galvanic skin response sensor needs further thought into where the electrodes should be placed 
for proper readings to ensue. All sensors present acceptable precision and accuracy values within 
the proposed environment; improvements still need to be made for increased performance. Once 
resolved and perfected, validation studies should verify the preliminary trends of Rett patients’ 
hand stereotypy quantification and palpation by expert versus novice hemodialysis nurses.  
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CHAPTER ONE: A BIOMETRIC APPROACH TO ANALYZING RETT SYNDROME’S 
ABNORMAL EPISODIC BEHAVIOR 
 
INTRODUCTION 
Rett syndrome (RTT) is a postnatal neurodevelopmental disorder that occurs primarily in 
females.1 One in approximately 10,000 births suffers from RTT which is produced by a mutation 
in the X-linked methyl CpG binding protein 2 (MECP2).2 The disease progression begins with 
normal growth and development during infancy until six to eighteen months, then there is a 
noticeable loss of motor control combined with speech impairment.  The degradation of motor 
skills eventually results in apraxia: a motor disorder where there is difficulty in motor planning 
to perform tasks.1 Compulsive hand movements such as mouthing, wringing, tapping, and 
washing are identifiable abnormal, involuntary movements classified as an episode.  
Rett syndrome can present with a range of disabling symptoms ranging from mild to 
severe. The progression and severity of Rett syndrome is determined by the location, type and 
extent of her mutation and X-inactivation. Therefore, two girls of the same age with the same 
mutation can express symptoms differently. This makes the treatment of this particular disease 
unique on a case by case basis.3 
There is no cure for RTT, so treatment focuses on the management of symptoms and 
improving quality of life.3 This includes limiting these previously discussed abnormal episodes 
so patients may have increased motor control. Drug treatments are still in trials with 
effectiveness based on physician observation, which is for a limited time and can be error-prone.  
Pharmaceutical companies need a way to quantify whether the drugs are in fact making an 
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impact on the patient in a positive way and to what extent. The goal of this project was to 
develop a wearable device that utilizes sensor fusion to quantify the abnormal episodic behavior 
of Rett syndrome so that symptomatic events can be further analyzed and broken down in terms 
of frequency, duration, and severity. 
 
RESEARCH DESIGN AND METHODS 
 The materials utilized primarily consisted of sensors with their supporting hardware and 
software.  The sensors chosen each were extracting a unique biometric in hope that when 
combined will provide useful insight into the symptoms of the RTT patient. As can be seen in 
Figure 1, the sensors were sewn onto a lightweight, incognito compression sleeve made of nylon.  
The sleeve needed to be lightweight and breathable so it would not interfere with the patient’s 
everyday life; concurrently, the sleeve needed to keep the attached sensors in close proximity to 
the desired locations along the arm.  
Figure 1.  Sleeve overview 
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 The Feather 32u4 Adalogger produced by Adafruit is the heart of this sensor based 
device.  The Feather which can be seen in Figure 2 is equipped with an ATmega32u4 logic chip 
running on 3.3 V logic/power at 8 MHz.4 The built in microUSB, microSD, and battery port 
allow for easy program uploading, data saving, and battery charging respectively.  Because we 
are recording sensitive patient data we wanted to store the information on an SD card which can 
be easily given to the patient’s presiding physician upon the next visit to the neurology clinic. 
The Feather is powered by a 500 mAh, 3.7 V lithium ion polymer battery which is more than 
sufficient to power the sensors we have chosen to run for multiple hours. The I2C, SPI, serial, 
and analog capabilities of the Feather were of particular interest to us for this project due to some 
of the sensors outputting a raw analog signal and some outputting a signal for I2C protocol. 
Briefly, I2C is a serial protocol using only two wires: SCL (serial clock) and SDA (serial data) to 
connect microcontrollers to peripherals.5 Each I2C slave device (BNO055, HR, etc…) has a 
unique 8-bit address that arranges the order of the serial communication with the master device 
(Feather 32u4 Adalogger). This organizational technique allows for almost unlimited number of 
I2C slave devices to communicate with the master.5  
Figure 2. Feather 32u4 Adalogger with battery and SD card components 
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 The first sensor we will be discussing is the MyoWare Muscle Sensor by Advancer 
Technologies.  For the reason that Rett syndrome’s episodic behavior can usually be identified 
by a variation of periodic hand motions, it is paramount that our device can record forearm 
muscle activity as well as hand usage.  The MyoWare Muscle Sensor, Figure 3, is able to record 
electromyography (EMG) which can be directly related to hand or arm activity.6  An 
electromyograph detects the electric potential generated by skeletal muscle cells.7 We chose to 
place this sensor on the extensor digitorum muscle of the forearm, Figure 5, in hope that the 
MyoWare will be able to verify the motion captured by the accelerometers and gyroscopes on 
the elbow and wrist while at the same time recording fine finger movement the motion sensors 
may not be able to record.  
Figure 3. MyoWare Muscle Sensor (.82” x 2.06”)        Figure 4. Cognionics Ag/AgCl electrode 
    
Figure 5. EMG location on forearm along extensor digitorum  
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 The MyoWare Muscle Sensor requires the use of three separate electrodes: two for which 
the EMG can be recorded between and one for a reference to an inactive adjacent muscle. The 
industry standard for electromyography electrodes is the Ag/AgCl wet electrodes.  We needed 
three reusable electrodes that would provide the equivalent level of sensitivity as the industry 
standard without degradation in signal quality after multiple uses.  We chose to use Cognionics’ 
dry, gel electrodes, Figure 4, because they have run numerous comparison tests verifying their 
dry electrodes are statistically similar to the industry standard which can be seen below in   
Figure 6.8 The pad diameter is .67” and easily snaps on to the Myoware Muscle Sensor.   
Figure 6. Wet electrodes compared to Cognionics’ dry, gel electrodes in response to a stimulus 
 
These dry electrodes have a pocket of conductive gel containing an undisclosed combination of 
salts and electrolytes to act as a transition region for transmitting the electrical activity from 
under the skin to the Ag/AgCl core.8 The Ag/AgCl core of these electrodes is what connects to 
the Myoware Muscle Sensor where the signal can be filtered and then transmitted to the Feather 
microcontroller via analog signal for data logging.   
 The second sensor we will be discussing is the BNO055 Absolute Orientation Sensor by 
Bosch.  This sensor will be placed at both the elbow and the wrist as can be seen in the sleeve 
overview in Figure 1.  We decided the motion at the wrist when compared to the elbow would 
provide novel, more reliable data for better determining the orientation of the patient’s arm. The 
BNO055 is our core motion tracking sensor sized at only 0.15” x 0.21”. The BNO055 contains a 
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32-bit cortex M0+ microcontroller running Bosch Sensortec sensor fusion software which is 
responsible for providing reliable orientation information in the form of Euler angles (360° 
sphere). The triaxial 14-bit accelerometer allows us to extract the true linear acceleration vector 
Figure 7. BNO055 Absolute Orientation Sensor with axes defined 
             
without gravity.  The triaxial 16-bit gyroscope has a range of ±2000 degrees per second which 
permits us to analyze the angular velocity about each individual axis (Figure 7).9 This is a nine 
degrees of freedom sensor connected to the Feather microcontroller via I2C protocol. 
 The third sensor we have attached to our sleeve is the Galvanic Skin Response Sensor 
(GSR) by Grove Electronics (Figure 8).  This sensor is sized at only 0.12” x 0.2”. There are two 
input electrodes made of nickel that we modified and placed at the proximal and distal ends of 
the forearm which can be seen in Figure 1 demarked by “Sensor and Component ‘4.’” The GSR 
sensor measures the resistance between the two electrodes and outputs an analog voltage reading  
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Figure 8. Galvanic Skin Response Sensor (GSR) by Grove Electronics with two finger electrodes 
 
between 0 mV and 1023 mV.10 We have programmed the GSR sensor to take some readings 
when the device is first turned on in order to determine the threshold resistance which we can 
subtract from the subsequent readings.  By doing this we are normalizing the GSR readings to 0 
so we can more easily see the relative change in resistance.  Grove recommends when the two 
electrodes are placed on the index and middle fingers that a change in voltage of 60 mV or 
greater is indicative of an emotional response. Galvanic skin response or electrodermal activity is 
relying on the positive correlation between perspiration and anxiety.  Ideally, when someone is 
feeling more anxious they sweat a little and the GSR sensor picks up on the decrease in 
resistance between the two electrodes.10 As we stated before, this change in resistance is 
conveyed via an analog voltage reading to the Feather microcontroller for further analysis.  
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 The Pulse Sensor Amped by World Famous Electronics is the next sensor we have 
chosen to utilize. We placed the Pulse Sensor Amped on the exterior of the wrist where one 
would wear a watch (Figure 1).  The Pulse Sensor Amped is only 0.625” in diameter (Figure 9). 
Figure 9. Pulse Sensor Amped conveying the emitter, detector, and size 
                                 
It utilizes photo-plethysmography (PPG) to determine the beats per minute (BPM) of the patient. 
PPG is used in reflective configuration for the Pulse Sensor Amped meaning the green light-
emitting diode (LED) emits light into the tissue and then the reflected light is measured via a 
detector photodiode on the same side of the tissue.11 The integrated on board circuitry is a 
combination of amplifying and filtering circuit components used to measure and smooth the 
backscatter green light intensity.  When the Pulse Sensor Amped is not in contact with any skin 
the analog signal hovers around the mid-point of the voltage, or V/2. When in close contact with  
Figure 10. The red curve represents the pulsed light reflection about V/2 (green line) 
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skin, the change in reflected light as blood pumps through the illuminated tissues makes the 
signal fluctuate around V/2 (Figure 10).11 The reason for the reflected light intensity fluctuating 
as a result of the blood pumping through the illuminated tissues is due to the blood volume itself 
actually fluctuating which can be seen below in Figure 11. To verify the BPM we are recording 
Figure 11. Pulse added volume demonstrated  
 
is accurate, we have placed a separate pulse sensor over the radial artery.  
 The MAX3010 made by Maxim Integrated is only 0.22” x 0.13”.  The MAX3010 has the 
capabilities to record pulse oximetry should this measurement prove to be useful for indicating 
when a Rett patient is sporadically ventilating.  Because of this capability in addition to being 
able to record the patient’s heart rate, the on-board circuitry has additional ambient light filtering 
which could prove useful for cleaner BPM readings when outside in sunlight (Figure 12 & 13).12  
Figure 12. MAX3010 by Maxim Integrated 
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The MAX3010 also utilizes a dim red LED opposed to a bright green LED on the Pulse Sensor 
Amped.12 The color of the LED emitter may come in to play under variable lighting conditions. 
Figure 13. MAX 3010 block diagram describing signal acquisition and filtering of PPG   
 
Unlike the analog output by the Pulse Sensor Amped, the MAX3010 operates via I2C protocol 
with the Feather microcontroller. The reflective PPG measuring principle is the same for both 
heart rate sensors; only the filtering hardware is slightly different.  We want these two heart rate 
sensors to verify each other’s BPM readings and hopefully act as a fail-safe should the sleeve 
shift position on the forearm during use.  
 We were not able to record data from actual Rett Syndrome patients at this stage in our 
device progression, but we were able to take readings from students within the Clemson 
bioengineering department while they mimic Rett hand stereotypies to the best of their ability. 
These trials will not provide insight into the biological indicators (i.e. heart rate and galvanic 
skin response) for Rett patients’ abnormal episodes, but they will provide similar motion data to 
what we expect to receive from a Rett patient.  This information can be further analyzed for 
automatic symptom detection/classification.  Therefore, the interesting data we will be looking at 
for extracting important features from these preliminary trials is the raw EMG, Euler angles, 
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linear acceleration, and angular velocity. The trials will also offer a better understanding of the 
capabilities and reliability of the sleeve design.  
 The setup for each trial entails a brief background of Rett Syndrome, an explanation of 
the protocol for each trial, and the data acquisition phase.  We provide a basic summary of the 
disease and more specifically describe the hand stereotypies we want the participant to mimic.  
We then show the participant a few video clips from online sources of Rett patients having an 
episode of stereotypical periodic hand motions. Tapping, hand wringing, mouthing, and any 
combination of these three hand stereotypies are the symptoms we have asked our participants to 
imitate to the best of their ability.  Tapping is simply moving the hand up and down periodically.  
Hand wringing is as if they are washing their hands in a cyclic pattern towards the midline of 
their body. Mouthing is where they raise their hands towards their face and are periodically 
tapping their mouth. The protocol consists of three 5:30 minute trials per participant.  
Figure 14. 5:30 minute individual trial protocol reminder cues  
               
Within each trial the participant is asked to remain still for the first thirty seconds so the sensors 
can normalize.  After thirty seconds the participant is asked to mimic the tapping motion Rett 
syndrome patients frequently experience involuntarily for thirty seconds. The participant then 
moves normally for thirty seconds where they can text, tell a story expressively, any kind of non-
periodic motion to express the normal behavior when the Rett syndrome patient is not having an 
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abnormal episode. The participant is now 1:30 minutes in to the trial; they now reproduce hand 
wringing behavior for thirty seconds.  At 2:00 minutes they again perform normal, non-periodic 
random hand movements. After thirty seconds of normal hand motion they recreate the mouthing 
hand stereotypy commonly observed in Rett patients for thirty seconds.  At the 3:00 minute mark 
the participant, again, performs normal hand motions for thirty seconds followed by any 
combination of hand wringing, tapping, and mouthing until the 4:00 minute cue. The previous 
minute is repeated from 4:00 minutes until 5:00 minutes where the participant is then asked to 
remain still at the 5:00 minute mark for thirty seconds until data collection for trial one has 
concluded.  The outlined protocol we have on display for the participants can be seen above in 
Figure 14. There were fifteen participants for a total of forty-five trials. This data was saved for 
further analysis.   
PRELIMINARY RESULTS AND SENSOR VERIFICATIONS 
Figure 15. An example of the linear acceleration (m/s2) along the y-axis of the BNO055 sensor 
located on the wrist during one trial 
 
13 
 
Figure 16. An example of the rotational velocity (m/s) about the y-axis of the BNO055 sensor 
located on the wrist during one trial 
 
Figure 17. An example of absolute orientation defined as Euler angles (°) along the y-axis of the 
BNO055 sensor located on the wrist during one trial 
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Myoware Muscle Sensor Verification 
Statement of Purpose: Electromyography (EMG) is used to detect muscle stimulation through 
the change in electric potential generated by muscle contraction.7 EMG data is essential to 
detecting hand stereotypies in Rett Syndrome: EMG has the ability to determine the magnitude 
of the muscle contraction to which the electrodes are attached. Our Myoware Muscle Sensor’s 
electrodes are placed in the middle of the extensor digitorum because this muscle is used in 
varying amounts during phalange, wrist, and elbow extension.13 The BNO055 sensors on the 
elbow and wrist are not capable of detecting phalange motion which is important for classifying 
the type of abnormal episode a Rett patient is experiencing. For instance, phalange extension is 
periodically different during tapping, hand wringing, and mouthing. In addition, the raw EMG 
signal will act as a fail-safe for verifying the macro motion data acquired from the two BNO055 
sensors.  
Methods: In this verification, the sleeve was placed on the participant’s arm where the Myoware 
Muscle Sensor is approximately two to four inches from the elbow and is centered on the 
posterior of the forearm. The participant was then asked to go through a series of phalange 
movements that are common to neurodevelopmental disorders and have a higher periodic 
frequency but a low magnitude in order to test the sensitivity of the sensor. We asked three 
participants to remain still for thirty seconds and then to perform four movements in thirty 
second intervals. The list of movements consisted of resting hand tremor (RHT), pill-rolling 
tremor (PRT), hand writing (HW), and typing (T). This process was performed once while 
wearing the sleeve with the Myoware Muscle Sensor and once with a Clemson University EMG 
in combination with the LabTutor software for a total of six trials (three with each EMG).  
15 
 
We used the industry standard wet gel electrodes for the Clemson University EMG (Figure 18) 
opposed to the novel dry gel electrodes for the Myoware Muscle Sensor. The trials were kept  
Figure 18. Clemson University EMG wet gel electrodes on the extensor digitorum 
 
identical with the same approximate lead placement, the same list of motions in the same order, 
and the same calculation techniques. When one of the four classified motions was being 
performed we classified it as active state and when the hand remained motionless we classified it 
as resting state.  The relative change in electric potential was determined by calculating the root 
mean square (RMS) of the electric potential of each of the four active states and then subtracting 
the RMS of the electric potential associated with the resting state. It has been documented that 
there is a linear relationship between contraction force and EMG RMS.14 The average change in 
electric potential (ACEP) was then calculated by averaging the three trials’ relative electric 
potential changes that were calculated for each of the four motions. The calculated ACEP results 
were then compared between the sleeve’s Myoware Muscle Sensor and the Clemson University 
approved EMG device (Figure 19).  
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Results:  
Figure 19. Results comparing the average change in electric potential for each hand motion 
 
Table 1. Results comparing the average change in electric potential for each hand motion 
 
Conclusions: Both EMG sensors were able to pick up a change in electric potential between 
active and resting states. The sleeve’s Myoware Muscle Sensor recorded a higher electric 
potential in all four active states but with a slight increase in variability. The elevated electric 
potential is not concerning because the gain on the Myoware Muscle Sensor can be adjusted if 
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voltage accuracy becomes important. For our purposes right now, we only need to see a 
proportional change in electric potential.  The Myoware Muscle Sensor passed this verification 
due to its ability to detect a noticeable change in electric potential which can be later used to 
determine if a Rett Syndrome hand stereotypy is taking place.  
BNO055 Motion Sensor Verification 
Statement of Purpose: The sleeve must be able to record samples at a sufficiently high frequency 
so that important motion data will not be missed.  The highest periodic motion frequency we 
expect to encounter with a Rett Syndrome patient will be in the form of a low magnitude, rapid 
jitter or a tremor. Table 2 details three common tremors and their known frequencies.  
Table 2. Known characteristics of involuntary movement disorders 
 
Methods: The BNO055 was tested at 4, 7 and 18 Hz, which represented the low, medium, and 
high-end frequencies of common movement disorders. We secured a platform to an old speaker 
which can be seen in Figure 20; the speaker acts as our medium for oscillation.  The input 
voltage given to the speaker was set to Vin = 5V and the function generator was set to recreate a 
sine wave at the frequency of interest. The BNO055 was then secured to the platform and turned 
on. Next, the exact procedure for each frequency is detailed in Table 3, three trials per frequency. 
For example, we recorded four minutes of motion data for 7 Hz three separate times.  
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Figure 20. BNO055 platform attached to oscillating speaker 
 
Table 3. Protocol for data acquisition at each frequency 
 
The motion data was converted into frequency domain (Figure 21), so we could compare the 
recorded frequency to the known input frequency (Figure 22). The average correlation 
coefficient was recorded for each frequency to determine precision.  
Results:                                                                                                                                     
Figure 21.  BNO055 motion data converted to frequency (Hz) domain   
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Figure 22. Function generator input frequencies compared to motion data frequencies 
 
Table 4. Correlation coefficient between trials recorded at the same frequency  
 
Conclusions: The BNO055 verification test was a success. It can be clearly seen in Figure 21 
that the predominant frequencies recorded were at 4 Hz, 7 Hz, 13 Hz, and 18 Hz. In Figure 22 
and Table 4 it can be easily seen that the BNO055 is able to accurately and precisely record 
periodic motion data at frequencies of 4 Hz and 7 Hz.  The reason there are frequencies being 
recorded around 13 Hz is due to the platform design not moving as one with the speaker at 
frequencies as high as 18Hz; the poor correlation coefficient and inaccuracy of the trials at 18 Hz 
is not due to the sampling rate of the BNO055 being set below the Nyquist frequency.  We 
would also like to note that it is unlikely Rett Syndrome patients will experience hand 
stereotypies with frequencies anywhere near 18 Hz unless they are diagnosed with orthostatic 
tremors in addition to Rett Syndrome. For these reasons we pass the BNO055 as a sufficient 
sensor for tracking periodic motion.  
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Galvanic Skin Response Sensor Verification 
Statement of Purpose:  We are looking to investigate whether or not biological signals can serve 
as precursors to tremors and other symptoms of neurological movement disorders, specifically 
dyskinesia, dystonia, and gait impairment related to Rett Syndrome.16 In our Rett Syndrome 
sleeve, detection of changes in heart rate and/or galvanic skin response will be analyzed to 
determine symptom presence and severity. One biological signal of interest is Galvanic Skin 
Response (GSR); GSR can change in response to stress, discomfort, or in reaction to unexpected 
circumstances, such as a tremor or other abnormal periodic episodes. It is, therefore, critical to 
verify that the GSR electrode placement on our sleeve permits the sensor to function accurately 
and precisely during patient free living in everyday life. To ensure this is the case, GSR 
electrodes will be tested on the recommended location, the fingers, and our sleeve’s electrode 
location (Figure 1).  
Methods:  This verification study used five healthy subjects for two trials each. Each participant 
is first told how the test will operate, then the Grove GSR electrodes are placed on the subject’s 
fingers (Figure 23). Next, the participant is instructed to sit on an Epic A17u Upright Exercise 
Figure 23. Grove’s recommended electrode position for measuring galvanic skin response  
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Bike, and the device begins recording for a period of six minutes.  The intervals of resting and 
pedaling are outlined in Table 5.  Ten minutes after the first trial, when the electrodes are on the 
fingers is completed the participant is then asked to wear the sleeve and perform the same 
resting/pedaling tasks. The data from trial 1 is compared to trial 2 by finding a correlation  
Table 5. Individual trial protocol for resting/pedaling while measuring the galvanic skin response  
 
coefficient (Table 6).15 This comparison ultimately aims to highlight the similarities between the 
clinically accepted value produced by the placement of the electrodes on the fingers versus our 
sleeve electrode placement.  
Results:  
Figure 24. One trial with electrodes on fingers where normalized resistance is plotted over 
sample number  
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Figure 25. Subsequent trial with electrodes at forearm location where normalized resistance is 
plotted over sample number  
 
Table 6. Five participants with a corresponding correlation coefficient comparing efficacy of two 
trials’ electrode position  
 
Conclusions:  Both GSR electrode placements, on the fingers and forearm, do successfully 
measure resistance of the skin. For example, both sets of data exemplify a decrease in resistance 
once the subject began pedaling. Unfortunately, the resistance recorded by the sensors on the 
fingers tended to rapidly normalize during resting periods while the resistance of the sleeve’s 
electrodes on the forearm failed to normalize. The average correlation coefficient was 0.640 
which is a positive correlation coefficient, but not quite our target of at least 0.70. We used 
correlation as a method of assessing the association between two continuous variables, one being 
GSR data from the forearm and the other from the fingers.15 Improvements in testing design 
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could include looking for shifts in general trends of resistance rather than a direct correlation. A 
probable explanation for the sleeve’s electrode placement not allowing the resistance reading to 
normalize could be due to the sleeve preventing the skin in contact from drying at the natural 
rate. The average correlation coefficient is below 0.7, so the Galvanic Skin Response Sensor 
failed this verification due to its inability to reliably measure a change in skin resistance when 
electrodes are placed anteriorly at the proximal and distal ends of the forearm.   
Pulse Sensor and MAX3010 Verification  
Statement of Purpose: It is known that non-motor biological signals can serve as precursors to 
tremors and other symptoms of neurological movement disorders, such as dyskinesia and gait 
impairment.16 Another biological signal of interest is heart rate, elevated heart rate is indicative 
of the subconscious anxiety that a patient experiences prior to a symptomatic episode.17 We also 
would like to record heart rate during abnormal episodic behavior in Rett patients to document 
any interesting fluctuations from the patient’s normal heart rate.  It is therefore critical to verify 
that the Rett Syndrome sleeve’s heart rate monitoring system is functioning accurately and 
precisely during patient free living of everyday life. 
Methods: We used five healthy subjects with no known heart conditions for four 1-minute trials 
(20 trials total). Subjects placed the Clemson finger heart rate monitor onto the distal phalanx of 
their right index finger and secured the monitor in place using a Velcro strap (Figure 26).  
Figure 26. Clemson University heart rate monitor secured to the right index finger 
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The finger heart rate monitor was hooked into the lab monitor and a steady pulse wave was 
obtained in LabChart. Simultaneously, the sleeve was put on and adjusted so the Pulse Sensor 
was snuggly on the posterior wrist and the MAX3010 was secured over the wrist’s radial artery. 
A timer was set for t = 1 minute, and all three devices collected the raw heart rate signal. After 
one minute, data collection was stopped and analyzed. The data collected from the Clemson 
University heart rate finger monitor was visualized and interpreted via the LabChart program 
where beats per minute (BPM) were easily calculated via peak-to-peak method (Figure 27).  
Figure 27. Clemson University heart rate finger monitor’s raw PPG waveform displayed in 
LabChart with peak-to-peak demarcation for BPM calculations 
 
The data collected from the Pulse Sensor and the MAX3010 each have a program written to 
determine the BPM; these BPM readings are then averaged and are now ready for comparison. 
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Results: 
Table 7. Clemson University heart rate finger monitor’s BPM compared to the averaged BPM of 
the MAX3010 and Pulse Sensor 
 
Figure 28. Graphical representation of the comparison between heart rate monitoring devices 
 
Conclusions: As seen in Figure 28 and Table 7, the mean BPM of the MAX3010 and Pulse 
Sensor when placed on the wrist are on average off by less than 1.35 bpm from the industry 
standard finger pulse monitor. The sleeve’s heart rate analysis and sensor location pass this 
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verification test due to their ability to reliably measure beats per minute as long as the sleeve is 
secured in the desired position.  
CONCLUSIONS 
 The verification tests were necessary to prove the sensors we have chosen not only 
operated to the manufacturers’ specifications but that the sensors were capable of operating 
reliably and accurately within the patient environment.  The EMG and BNO055 sensors proved 
to accurately record periodic motion data at frequencies closely associated to Rett syndrome and 
similar diseases. Having a BNO055 sensor at the elbow and wrist allows us to interpret the 
orientation of the arm during the abnormal episodes of Rett Syndrome. If the patient is simply 
tapping her hand then little to no motion will be present at the elbow but periodic motion at the 
wrist will be present.  If the patient is wringing her hands then there is a certain degree of 
twisting of the forearm involved.  This means the Euler Angles, linear acceleration, and 
rotational velocity data will have different distributions and amplitudes at the wrist and elbow. 
The amplitude of the EMG will also vary depending on the type of hand stereotypy the patient is 
experiencing.  This is important to note moving forward with this project because the more data 
that indicates the type of hand stereotypy a patient is experiencing the more confident we can be 
in an automatic episode classification algorithm.  
 It has yet to be determined if the heart rate or galvanic skin response of the patient will 
provide any indication that the patient is experiencing an abnormal episode.  This can only be 
determined by recording data on patients who have Rett syndrome.  We wanted to still go ahead 
and verify the two heart rate sensors and galvanic skin response sensor were able to record 
accurately.  The heart rate sensors are absolutely able to record beats per minute when placed on 
the wrist opposed to on a finger which is very promising; however, a key issue that must be 
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addressed in any wearable biometric device is the inevitability that the sensors may not remain in 
the desired location resulting in a discontinuous data stream. For this reason, we placed two heart 
rate sensors in two different locations in hope that at least one of them will be able to pick up the 
heart rate of the patient at any given time. Moving forward with the project, it needs to first be 
determined if heart rate is a useful metric for determining the duration, severity and type of hand 
stereotypy the Rett patient is experiencing. If it is determined heart rate is a useful metric then a 
method for reliably measuring heart rate utilizing these sensors must be employed.  
The galvanic skin response sensor accurately recorded data when the electrodes were 
placed on the fingers but failed to accurately record data when placed at the proximal and distal 
ends of the forearm. This failure is most likely due to the sleeve itself not allowing the skin 
beneath the sleeve to be exposed to the air directly.  The galvanic skin response sensor relies on 
the change in resistance between the two electrodes and if the sleeve is not allowing perspiration 
to evaporate properly then the resistance measurement will be inaccurate. Moving forward it 
must be determined if galvanic skin response is a useful metric for determining duration, 
severity, and type of hand stereotypy Rett syndrome patients are experiencing. If it is determined 
galvanic skin response is a useful metric then the proper placement of the electrodes for accurate 
and reliable data acquisition must be addressed.  
 The Rett sleeve provides a novel way of measuring patient symptoms and offers 
unprecedented insight about the disease itself. Having a noninvasive continuous monitoring 
system allows the clinician to quantify the duration, severity, and type of symptoms the patient is 
experiencing.  This is important because the clinicians’ only form of information currently comes 
from what they observe in the clinic and what the parents of the patient tell them.  Data collected 
in the clinic often can be skewed as a result of the patient being in an intimidating, unfamiliar 
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setting. Unbiased, at home data is important for understanding the mechanics of the disease and 
the lifestyle of the patient.  This sleeve does not only have the potential for helping clinicians 
better understand Rett syndrome but also many neurodevelopmental disorders such as 
Parkinson’s disease, essential tremor, autism spectrum disorder, and many others. Biometrics is a 
quickly growing industry affecting everyday life in the form of measuring vitals and tracking 
fitness; applying the same sensor based methodology to patients is the future of improving 
quality of care.  
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CHAPTER TWO: ANALYZING ATRIOVENTICULAR FISTULA CANNULATION SKILL 
 
INTRODUCTION 
Kidneys are organs in the body that are integral in the blood purification process. Kidney 
failure can eventually lead to the diagnosis of Chronic Kidney Disease (CKD); the ultimate stage 
of CKD is known as End Stage Renal Disease (ESRD).4 Treatment options are extremely 
limited. The only methods available are to receive a kidney transplant which could take years to 
find a match, or to undergo dialysis treatment. In the United States alone, there are 100,000 
people on the transplant list but fewer than 20,000 donors are able to be considered.1 This leads 
to the increased use of dialysis.  
There are two kinds of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is the 
far more common type of dialysis—about 90% of all dialysis patients.1 Hemodialysis requires 
the patient to undergo a process three to four times a week, four hours a session. Hemodialysis is 
a tedious procedure to perform correctly, requiring the technicians to have a high degree of skill. 
First, an arteriovenous (AV) fistula must be created by a surgeon in the upper forearm, and this 
will be the target area to cannulate.2 Technicians are required to locate the AV fistula, find a 
proper cannulation point, and cannulate the fistula in order to externally purify the blood using a 
machine known as a dialyzer (Figure 29).3,5 These steps require meticulous care and an acute 
amount of expertise in order to conduct the procedure flawlessly. Unfortunately, there aren’t 
many resources or systems that are effective in training technicians to properly palpate for the 
fistula or accurately cannulate the fistula with a needle. Nurses are instructed to only locate a 
mature fistula if it is superficial, large, and straight enough to allow for safe insertion of two 
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needles.5 In order to localize the ideal location for cannulation, nurses are taught to use the thrill 
and bruit of the fistula. The thrill refers to the constant vibration that is distinguishable from the 
pulses that can also be felt. The bruit refers to the constant whooshing sound that is a result of the 
blood flowing through the fistula.2 These are generally the only guidelines that are provided to 
Figure 29. Hemodialysis 
 
nurses prior to cannulation. This is a significant issue in the medical community due to the high 
frequency of cannulation procedures each hemodialysis patient must undergo. Dialysis is 
exhausting for patients and fraught with morbidity and eventual mortality. Only 35% of 
hemodialysis patients remain alive after five years of treatment.1 Patients are less likely to 
consistently meet all of their dialysis appointments and needs if cannulation procedures are an 
uncomfortable or even painful experience due to improper cannulation technique.  There is a 
growing need for an improved training protocol that adequately provides the necessary skills to 
inexperienced technicians for a widely used ESRD treatment that annually affects over 200 
million patients worldwide. 
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RESEARCH DESIGN AND METHODS 
The experiment heavily relies on three physical components: the simulator, the camera, 
and the Leap Motion sensor. A stand was constructed to place the Leap Motion sensor and 
camera 43 cm and 81 cm respectively above the simulator. 
 
Simulator 
Inside a plastic outer shell, diameter of 58.50 cm, are six even pie piece sections of foam 
that represent the six distinct regions that will be felt during palpation. Each region houses a 
fistula model that may be vibrating for the duration of each trial in the experiment (Figure 30). 
Figure 30. Simulator overview 
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Our six model fistulas are dimensioned at 3 x 3 x 14.5 cm; the target region is the raised vessel 
with an area of 1.75 x 14.5 cm (Figure 31). The target region is an anatomical representation of a 
mature fistula.  A fistula is placed in an aberrant manner within each of the six regions such that 
it is not obvious for the participant to determine its location. There are vibrational motors that are 
connected to the underside of both end points of each fistula. The vibratory stimulus is similar to 
the thrill that can be felt on a mature AV fistula.  Of the six fistulas, only one pair of vibrational 
motors will be buzzing at a time during a single trial; therefore, the vibrating fistula’s target 
region is the desired cannulation location. A controller allows us to cycle through which one of 
the six fistulas is vibrating for the current trial. 
Figure 31. One of six fistula models 
 
The final element of the simulator is the synthetic skin that is placed on the top of the 
simulator (Figure 32). The synthetic skin was created using a silicone rubber material called 
Smooth-On. Smooth-On has a set cure time but can be shaped into whatever mold it is poured in 
before it cures. The silicone and rubber components give the skin an elastic, loosely dense feel.   
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The synthetic skin hides the position of the six fistulas, but when palpated on it is still 
discernable whether or not there is a fistula or only foam underneath.  
Figure 32. The simulator without and with the synthetic skin  
  
 
Camera 
 At this time, we have not planned on using our camera for post image processing for 
further analyzing palpation and cannulation technique, so we were not in need of a high end, 
rapid frame rate camera. We needed a camera that simply allowed us to visualize what was going 
on during a trial at particular time points of interest.  For instance, we need to be able to watch 
the video of the trial and record what times the participant started, found the cannulation 
location, and stopped palpating; we then would look at the recorded data from the Leap Motion 
sensor at those recorded time points of interest. We chose to use an HP Pro Webcam; it is able to 
record 30 frames per second for smooth and natural body motion at 640 x 480 video resolution 
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(Figure 33).6   The HP Pro Webcam easily integrates to the computer via USB 2.0 connection 
and can be used as the computer’s default camera once the driver is installed.  We utilized the 
Open Source Computer Vision Library (OpenCV) to integrate the webcam into our program.  
Figure 33. HP Pro Webcam 
 
The only downfall with this exact webcam is the field of view is not wide enough to be placed at 
the same height as the Leap, so the camera had to be placed 81 cm above the plane of the 
simulator in order to capture the entire palpation area. This camera is sufficient for visualizing 
palpation on the simulator at this time.  
 
Leap 
A crucial piece of information that must be observed is the palpation behavior of the 
subject when searching for the source of the fistula thrill. Finding the thrill source is one of the 
most challenging aspects of the cannulation procedure. Although there seems to be a relatively 
standard procedure to locate the fistula, tracking hand movement can lead to more methodical 
teaching practices that can improve cannulation training. In order to track the hand movement of 
the subject, many options for a motion capture device were considered. It was essential to find a 
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camera that was able to accurately and precisely record instantaneous finger positions at a 
sufficiently high sampling rate for at least a single hand.  
The Leap Motion controller is the ideal selection as its motion capture system was able to 
reliably track hand movements. The accompanying application program interface (API) is 
extremely versatile and permits a wide variety of metrics to be extracted from the user’s hand.  
The Leap Motion controller is most commonly used as novel interface to control software with 
the movement of hands and lately has been used in creating virtual reality applications. The 
software developer kit for the Leap Motion controller has pre-existing applications that allow the 
user to interact with a virtual object by rendering the user’s hand(s) into the virtual environment 
(Figure 34).7 Originally, the Leap Motion controller was designed to be placed on a flat surface 
Figure 34. The Leap Motion controller allowing interaction with the virtual world 
 
with its sensors facing upward and reading the movement of hand motion from underneath the 
user’s hands. Due to the increased use of the Leap Motion controller in virtual reality 
applications, the Leap Motion controller has improved adaptability in being able to reliably track 
hand movement from above the user’s hands.7 In this particular study, we will be taking 
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advantage of the Leap Motion controller’s ability to read precise and accurate hand movements 
in order to observe the palpation methods used by experts and novices alike. 
The Leap Motion controller uses infrared (IR) imaging to recognize and track hands, 
fingers, and finger-like tools. The exact details of how the IR cameras and emitters interact with 
Figure 35. Leap Motion controller exploded for sensor and camera visualization  
  
each other are not open to the public, but it can be postulated that the Leap Motion controller 
employs the stereo vision technique as there are two cameras that are able to relay information 
later to be used in combination in order to determine the precise depth of the particular object in 
question. The heart of the device consists of two cameras and three infrared LEDs which allows 
the Leap to track infrared light at a wavelength of 850 nm (Figure 35).7 The middle IR emitter 
Figure 36. Interaction volume with respect to Leap Motion origin is 2 ft above the controller, by 
2 ft wide on each side (150° angle), by 2 ft deep on each side (120° angle) 
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that is placed at the center of the front side of the Leap Motion controller is referred to as the 
origin. The Leap Motion controller is able to determine a litany of characteristics (which can be 
found on the API library), and this is due to its ability to determine the position of the object 
relative to the origin; the origin is the coordinate (0,0,0). The field of view from the origin is an 
inverted pyramid with a range from 25 to 600 millimeters (Figure 36).7 The data takes the form 
of a grayscale stereo image of the near-infrared light spectrum, separated into the left and right  
Figure 37. Stereoscopic gray scale image taken by Leap  
 
cameras (Figure 37). Images are then analyzed to reconstruct a 3D representation of what the 
device sees. The tracking layer matches the data to extract tracking information such as fingers 
and tools.7 
These characteristics of the Leap Motion controller make it a very suitable choice for 
capturing and observing precise hand and finger movement within a confined space. In this study 
we will be using the Leap Motion controller to record the positional data of the five fingers 
during palpation as well as the tip velocities for each finger. The next logical step was to verify 
the accuracy and precision of the five finger’s position data to ensure the Leap Motion controller 
can provide us with sufficient resolution for tracking palpation.  
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Leap Static Position Verification 
Procedure: We placed our index finger at the furthest most point of both ends of the six fistulas 
and recorded these twelve coordinates (x,y,z) using the Leap.  We then measured these same 
points from the origin of the simulator using a protractor and ruler. A t-test was then used to 
compare the Leap Coordinate's distance from the origin to the measured distance from the origin.  
Another t-test was then performed to compare the Leap Coordinate's tangent angle to the 
measured protractor angle with respect to the negative x axis. Figure 39 demonstrates the 
orientation of the Leap’s axes with respect the simulator. An example procedure for measuring 
the distance from the origin to the fistula endpoints as well as measuring the angle from the 
negative x axis to the same two endpoints on the fistula can be seen in Figure 38 and the results 
can be seen below in Table 8.  
Figure 38. Leap static position accuracy verification example 
 
41 
 
Table 8. Leap static position accuracy verification results 
 
 
Figure 39.  The Leap axes labeled with respect to the controller’s orientation in the experiment 
 
After repeating this procedure three times to ensure precision, we can confidently say the Leap 
coordinates are accurately indicative of the physical dimensions of the cannulation simulator 
having only a mean difference of 0.9 cm and 3° with p-values less than 0.05 consistently.  
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Protocol 
For each trial, the participant was asked to wear a white glove and to keep their hand 
above the simulator for five seconds to allow for the Leap Motion sensor to calibrate. The white 
glove causes a greater grayscale contrast between the simulator’s skin tone and the palpating 
hand which increases the reliability of the Leap.  After the calibration phase was complete, the 
participant was permitted to physically place their hand on top of the simulator, at which point 
the experiment’s timer was started. The participant then would palpate, feeling for differences in 
structure beneath the skin as well as differences in vibratory stimulus in order to determine an 
appropriate cannulation location along the indicated fistula. When the participant felt that they 
had reached an acceptable cannulation entry point, they placed their index finger on the location 
and verbally notified the conductor. After finding one location, the participant was asked to find 
two other acceptable points of entry along the same fistula approximately one inch apart if 
possible. Once the third point was identified, the trial was concluded. Each participant underwent 
three separate trials; the first and the third trials were for the fistula on which we will be 
performing palpation analysis. Once the three trials were concluded, the experiment was 
complete. 
 
Data Acquisition 
As the participant is palpating for the fistula, both the camera and the leap are recording. 
The code to analyze each trial was written in C++ on the Visual Studio 2013 IDE. The code was 
written on this medium in order to synchronize together both the visual feedback from the 
camera and the tracking data of the Leap Motion sensor using the computer clock. As detailed in 
Figure 40, it is essential to synchronize both accessories in separate threads. Threading allows for 
43 
 
instructions from the code to be operated concurrently; this ensures that the data from the Leap 
Motion sensor and the images from the camera were recording simultaneously.  
Figure 40. Detailed data acquisition to data analysis flow chart 
 
By employing threads, it is possible to use the computer’s clock to accommodate for the different 
acquisition rates of the camera and the Leap Motion sensor. The camera outputs a video file that 
is used as a reference to identify the points at which the participant indicates that they have 
located a viable point of needle insertion. The Leap Motion sensor is programmed to output a 
text file that records the following values for each frame: the frame ID, the time, the x-coordinate 
for each finger, the y-coordinate for each finger, the z-coordinate for each finger, the x-velocity 
for each finger, the y-velocity for each finger, and the z-velocity for each finger. These values 
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are imported into MATLAB and are used to create new metrics that are potentially valuable in 
evaluating the participant’s palpation skill (Figure 40 & 41). 
Figure 41. Overview of data path 
 
Metrics 
The participant was asked to identify three points on the fistula that they determined to be 
proper points of cannulation. Ideally one would find the three points indicated in Figure 42.   
Figure 42. Ideal cannulation locations along the fistula model  
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To classify whether the participant was successful in finding a proper cannulation location or 
not, the only point that was considered was the first point as this was the cannulation location 
they were most comfortable in identifying. If the coordinates of the first cannulation point were 
determined to be in the target area (denoted by the red rectangle in Figures within the RESULTS 
section) then the trial was considered to be successful. 
During the recorded trials, different palpation techniques were observed. There are 
several variations used by different subjects, some that are used by professionals, but most that 
were not. This is not surprising as most of these students had no prior experience in palpation. In 
order to get a sense of what techniques were used, their methods were divided into gross and fine 
palpation. Gross palpation was characterized as widening the palm and using the increased 
surface area to localize the fistula. Fine palpation was classified by clasping the fingers together 
to feel for more precise detail. It was expected that the participant would use gross palpation at 
first to determine the general direction of the fistula and then use finer techniques to 
meticulously pinpoint an acceptable cannulation location. 
The most basic metric to retrieve from the experiment is the time it takes for the 
participant to find the fistula. To find the exact trial duration, the time is taken from when the 
participant moves their hand after having placed it upon the simulator to the time when they 
indicate they have found the first viable point of cannulation. 
The path length metric is a scalar variable that signifies the total distance palpated by the 
participant to reach the first point of cannulation. This is calculated by recording the distance the 
index finger travels in between sequential frames and producing a collective sum. If the 
participant is not able to find a single cannulation point after moving their palm a total of 1 
meter, then it is highly likely that the participant is not capable of performing the task properly. 
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Ho: If the participant’s path length is greater than the average path length and the time taken to 
find the fistula is less than the average time, then there is no increase in gross palpation being 
used.  
Ha: If the participant’s path length is greater than the average path length and the time taken to 
find the fistula is less than the average time, then there is an increase in gross palpation being 
used. 
 The palpation depth corresponds to the y-value of the index finger’s coordinates. It is 
valuable to know where the participant is depressing into the skin during palpation the most 
because deeper palpation is potentially indicative of fine palpation. Fine palpation is generally 
used at points of interest to further analyze what the participant is feeling under the skin. During 
a trial the participant understands that the point of maximum vibratory stimulus is where the 
fistula to be found is located, so it can be hypothesized that as the participant’s hand increases in 
proximity to the fistula, palpation depth will increase.   
Ho: When the palpation depression depth is at least 10mm deeper than the mean palpation depth, 
over 95% of the participant’s data points are not within 60 mm of the fistula midpoint. 
Ha: When the palpation depression depth is 10mm deeper than the mean palpation depth, over 
95% of the participant’s data points are within 60 mm of the fistula midpoint. 
 The palpation velocity corresponds to the magnitude of the index finger’s velocity vector. 
Similar to the practical application of deeper palpation depressions, slower palpation velocity 
also is potentially indicative of fine palpation. It is important to note if the participant is slowing 
their palpation speed as they are palpating in close proximity to the fistula or if they are more 
slowly palpating in regions away from the fistula.  Should the participant palpate much slower in 
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regions not near the fistula to be cannulated then this participant may lack palpation skill.  One 
can hypothesize that as proximity to the fistula increases, palpation velocity should decrease due 
to the increased vibratory stimulus surrounding the fistula signifying to the participant that they 
are nearing an appropriate cannulation location.   
Ho:  When the instantaneous palpation velocity is at least 20% slower than the mean palpation 
velocity, more than 95% of the participant’s data points are not within 60 mm of the fistula 
midpoint. 
Ha: When the instantaneous palpation velocity is 20% slower than the mean palpation velocity, 
more than 95% of the participant’s data points are within 60 mm of the fistula midpoint. 
Understanding the orientation of the fistula needing to be cannulated is of the upmost 
importance because it is easy to perforate the blood vessel if the insertion angle is incorrect. The 
fistula orientation value is determined by plotting the locations of the three points on the fistula 
that the participant is asked to identify in the x-z plane. A linear regression is then plotted 
between the three cannulation locations. The slope of the linear regression is the participant’s 
orientation value for the trial.  If the participant’s calculated orientation value is close to the 
known orientation value of the fistula used then we predict he or she has the ability to locate a 
viable cannulation location.  If the participant is unable to determine a similar fistula orientation 
then they may lack palpation skill.   
Ho: When the participant’s slope between his or her three cannulation points and the measured 
slope of the fistula have less than a 10% difference, the participant’s indicated point of insertion 
is not within the accepted area of the fistula.  
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Ha: When the participant’s slope between his or her three cannulation points and the measured 
slope of the fistula have less than a 10% difference, the participant’s indicated point of insertion 
is within the accepted area of the fistula. 
The ratio value is a metric that compares the number of data points that were harvested 
inside the region that housed the correct fistula in relation to the total number of data points that 
were collected. The six pie shaped regions and their corresponding boundaries can be seen best 
in Figure 38. The ratio metric is valuable as it gives an approximation of whether the participant 
is able to quickly identify the source of the vibrating fistula. A ratio value of over 90% is 
indicative that the participant is more likely to identify a viable cannulation point and has a 
certain degree of palpation skill.  
Ho: If the ratio between the desired 1/6 and the rest of the simulator has more than 90% of the 
palpation points, then the participant will not succeed in finding a proper fistula point to 
cannulate. 
Ha: If the ratio between the desired 1/6 and the rest of the simulator has more than 90% of the 
palpation points, then the participant will succeed in finding a proper fistula point to cannulate. 
Ho: If the ratio between the desired 1/6 and the rest of the simulator has more than 90% of the 
palpation points, then the time taken to find the fistula will not be less than the mean time spent 
finding the same fistula. 
Ha: If the ratio between the desired 1/6 and the rest of the simulator has more than 90% of the 
palpation points, then the time taken to find the fistula will be less than the mean time spent 
finding the same fistula. 
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 Density is an important metric when classifying a participant’s palpation skill because an 
elevated density value location represents where a participant spent a significant amount of time. 
Where the participant spent most of his or her time is a potential metric for how skilled at 
palpation the participant is. The density value is simply counting how many index finger 
locations are within a circle centered on each index finger’s location and then divided by the area 
of the circle. Every index finger coordinate has a circular area around it, the density function 
counts how many other index finger locations are within that defined radius.  For example, if I 
were to hold my index finger in one location for an extended period of time then a high-density 
value would ensue because of all the samples collected at that particular location.  If I were to 
move my index finger at a constant velocity in an x-shaped pattern then the center of the x would 
have the highest density value because it is the only location that has a path intersection.  It is 
appropriate to hypothesize that high-density palpation locations will be where the participant 
feels something of interest under the skin which should be in close proximity to the fistula to be 
found. Should high density locations not near the desired fistula be prevalent then this participant 
may lack palpation skill.  
Ho: Palpation locations with a density value greater than 1 will not 100% of the time be within 
60mm of the fistula midpoint. 
Ha: Palpation locations with a density value greater than 1 will 100% be within 60mm of the 
fistula midpoint. 
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RESULTS 
Behavioral differences between novices who succesfully found fistula to those who did not. 
Table 9. Meaningful features relevant to measuring palpation skill (green is a successful trial) 
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Figure 43.  Three indicated cannulation locations color coded by trial (all 16 trials) 
 
Figure 44. Slope values from the linear regression through each trial’s three cannulation 
locations (1.95 is the actual slope of the fistula) 
 
 
Fistula 
Orientation 
1.95  
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Figure 45. Distance in millimeters between indicated cannulation location and fistula midpoint 
 
Figure 46. Angle in degrees, -180:180, from indicated cannulation location to fistula midpoint  
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Figure 47. Time in seconds needed to find a cannulation location  
 
Figure 48. Palpation path length in millimeters needed to find a cannulation location 
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Figure 49.  Percentage of palpation locations inside the correct one sixth of the simulator 
 
Figure 50. Proportion of gross and fine palpation used in successful vs. unsuccessful trials 
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Figures 51 & 52.  Index finger palpation path overlain with density topography (unsuccessful 
and successful examples anytime there are two figures side by side, the small black circle is the 
participant’s indicated cannulation location) 
   
                           unsuccessful                 successful 
 
Figures 53 & 54.  Index finger palpation path color coded with density values 
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Figures 55 & 56. Index finger locations with a density value greater than 1 
  
 
Figure 57. Percentage of palpation locations within 60 mm of the fistula midpoint that also have 
a density value greater than 1  
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Figures 58 & 59.  Index finger palpation path color coded with depth values 
   
 
Figure 60. Mean palpation depth used to find a cannulation location  
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Figures 61 & 62.  Index finger palpation locations with a palpation depression depth 10 mm 
deeper than the current trial’s mean palpation depth 
    
 
Figure 63. Percentage of palpation locations within 60 mm of the fistula midpoint that also have 
a palpation depth 10 mm deeper than the current trial’s mean palpation depth
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Figures 64 & 65.  Index finger palpation path color coded with velocity values (mm/s) 
   
 
Figure 66. Mean palpation velocity in millimeters per second used to find a cannulation location 
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Figures 67 & 68. Index finger locations where palpation velocity is 20% slower than the current 
trial’s mean palpation velocity 
  
 
Figure 69. Percentage of palpation locations within 60 mm of the fistula midpoint that also have 
an instantaneous palpation velocity 20% slower than the current trial’s mean palpation velocity  
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DISCUSSION & CONCLUSIONS 
 Palpation analysis is largely unprecedented aside from breast examination technique.  
There are not defined rules or procedures for how to palpate properly. The cannulation of an AV 
fistula requires palpation for finding the ideal needle locations in order for dialysis treatment to 
proceed.  We have detailed a few of our metrics, defined a protocol, recorded sixteen trials, and 
have provided some preliminary results. The analysis of these preliminary results is of the 
upmost importance before proceeding with the cannulation simulator research because it will 
structure the future design of the experiment.  
 The first metric we will be discussing is the fistula orientation value. Figure 44 divides 
the sixteen trials’ cannulation locations (Figure 43) into successful and unsuccessful trials.  Six 
out of sixteen participants successfully found an acceptable cannulation location. Out of those six 
successful trials only two orientation values were less than 10% different from the actual 
orientation value, 1.95. Only one trial was successful when the participant’s orientation value 
was more than 32% different. The mean orientation value for unsuccessful trials is 1.54 while the 
mean orientation value for successful trials is 1.73.  It is evident that palpating to determine 
fistula orientation is important for finding a successful cannulation location. Should we collect 
more trials, we believe this trend will become even more apparent and will be deemed a useful 
metric for predicting cannulation success.  
 The distance between the participants’ indicated cannulation location and the middle of 
the fistula can be seen in Figure 45.  Successful participants on average were 32.28 mm away 
from the fistula midpoint while unsuccessful participants were on average 60.21 mm away from 
the fistula midpoint. Neither of these statistics are surprising because the target region on the 
fistula model itself is approximately 120 mm in length, so it makes perfect sense that any 
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cannulation location more than 60 mm away from the fistula midpoint would be unsuccessful. 
Successful trials having an average of 32.28 mm distance from the fistula midpoint is not 
alarming because we did not ask the participants to find the midpoint of the fistula.  We simply 
asked them to find a viable cannulation location along the 120 mm fistula vessel. What may be 
interesting is that two unsuccessful trials were less than 30 mm away from the fistula midpoint 
but failed to find a viable cannulation location.  
 Palpation duration when combined with other metrics can provide insight into what kind 
of palpation technique was used to find the fistula. Figure 47 illustrates the time taken for 
successful trials versus unsuccessful trials to find a cannulation location. Successful participants 
on average palpated for 16.65 s before finding a cannulation location while unsuccessful 
participants spent 19.34 s palpating for the fistula. This is not very telling without being placed in 
context with other metrics such as path length, ratio values, and gross and fine palpation 
percentages. Figure 48 demonstrates unsuccessful participants had a much greater variability in 
path length with an average of 994.85 mm while successful participants remained more 
deliberate in their palpation path with an average path length of 728.31 mm. The mean ratio of 
palpation locations within the correct fistula region for successful participants is an incredible 
92.61 %; whereas, unsuccessful trials averaged a ratio of 78.42 % within the correct region 
(Figure 49). The average gross palpation used for successful participants was 61.43 % whereas 
the average fine palpation used for unsuccessful participants was 38.26 % (Table 9). It is 
important to note the ratio of fine versus gross palpation technique is almost exactly inversed for 
successful versus unsuccessful participants (Figure 50). In summary successful participants 
spend less time finding a cannulation location, have a much shorter path length, palpate in the 
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correct region of the simulator for a larger percentage of time, and use gross palpation for 2/3 of 
the trial.  What do these four metrics tell us about palpation skill and technique?   
These trends indicate successful participants are able to localize the source of the 
vibratory stimulus much more rapidly than unsuccessful participants which in turn results in a 
decreased palpation duration time, a shorter path length, and an increased ratio of palpation 
locations lying within the correct 1/6 of the simulator. Successful participants using fine 
palpation for only 1/3 of the trial makes sense because if they are more skilled in localizing the 
source of the vibratory stimulus then less time will be needed to find a viable cannulation 
location once they have arrived at the vibrating fistula. It also stands to reason that if 
unsuccessful participants lack skill in localizing the vibrating fistula then they will use a much 
larger percentage of fine palpation to verify whether they have or have not found the vibrating 
fistula beneath the simulator’s skin.  
It was noted that eleven participants had a trial duration time shorter than the mean,  
18.31 s, and that six participants had a palpation path length longer than the mean, 894.90 mm. 
Three out of the ten and two of the six participants were able to successfully find a viable 
cannulation location. Only one participant had a shorter trial duration than the mean and had a 
longer path length than the mean.  This one participant did not verify our hypothesis that there 
would be a substantial increase in gross palpation should both of these circumstances be met.  In 
fact, the exact opposite proved to be true; the participant used 75% fine palpation to find a 
cannulation location.  While the participant may have disproved our hypothesis for now, he was 
unable to successfully find a cannulation location so it is likely the participant simply lacked 
palpation skill.  More trials will need to be conducted to further disprove this hypothesis.  
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 We also hypothesized that if the ratio between the desired 1/6 and the rest of the 
simulator has more than 90 % of the palpation locations, then the participant will succeed in 
finding a viable cannulation location. We found that out of the six participants who found a 
viable cannulation location, four participants had a ratio greater than 90 %. Exactly half of the 
participants had a ratio greater than 90 %. These results incline us to believe this hypothesis will 
hold true should we take more trials. In parallel to the previous ratio hypothesis, we predict that 
if the ratio is greater than 90 % then the trial duration will be less than the mean trial duration. As 
stated before, eight participants had a ratio greater than 90 %, five of which also had a trial 
duration time less than the mean. These results incline us to believe this trend will continue and 
we will be able to validate our hypothesis. Both of these hypotheses essentially mean that if the 
participant is primarily palpating in close proximity to the vibrating fistula without wandering 
about the simulator then the trial will be a success. Therefore, ratio is a key metric for measuring 
palpation skill.  
 Density of palpation locations appeared to be a promising metric for quantifying 
locations of interest on the simulator. Figures 51, 53, and 55 are the same unsuccessful 
participant; Figures 52, 54, and 56 are the same successful participant. Figures 51 and 52 provide 
an illustration of the path the participant took to find their cannulation location, small black 
circle, with respect to the simulator as a whole. The palpation path itself is color coded with 
density values, blue being low density, and superimposed is the density topography which is also 
color coded with density values.  The yellow hotspots are where the participant palpated the 
most; thus, are areas of high interest for analysis. Zoom fitting Figures 51 and 52 to where each 
participant palpated on the simulator and removing the density topography leaves us with 
Figures 53 and 54.  It is much easier to discern the exact location where the palpation density is 
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high and low with the zoomed in path plots. The main thing to take note of is that the successful 
participant’s most dense locations are all along the fistula (red rectangle), but the unsuccessful 
participant has multiple high-density locations not along the fistula.   
We propose that high density locations not in close proximity to the fistula indicate a lack 
of palpation skill. Figures 55 and 56 further amplify this prediction by only plotting palpation 
path locations that have a density value greater than 1. (A density value greater than 1 means 
there are at least 78 palpation locations within 5 mm of a given coordinate along the palpation 
path.) Our hypothesis to test our prediction is that palpation locations with a density value greater 
than 1 will always be within 60 mm of the fistula midpoint.  The dotted gray circle encompassing 
the fistula represents the 60 mm radius circle which we initially believed to be an accurate 
representation of the extent of the fistula’s vibratory stimulus. It can be clearly seen that 100 % 
of the successful participant’s palpation locations with an associated density value greater than 1 
are well within 60 mm of the fistula midpoint. In contrast, the unsuccessful participant has less 
than 50 % of palpation locations with an associated density value greater than 1 within 60 mm of 
the fistula midpoint. These results are very encouraging because they support our hypothesis.  
Figure 57 is proof that the two examples shown in the previous six figures were not outliers. 
Successful participants had density values greater than 1 within 60 mm of the fistula midpoint on 
average 91.11 % of the time.  Unsuccessful participants had density values greater than 1 within 
60 mm of the fistula midpoint on average 23.37 % of the time.  After we take more trials, if we 
are able to able to further prove this hypothesis then we can say without a doubt that density 
values greater than 1 not in close proximity to the fistula are an indication the participant lacks 
palpation skill.   
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Palpation depth is the next metric we believed could have an interesting correlation with 
palpation skill. Figures 58, 61 and 59, 62 are respectively plots of the same unsuccessful and 
successful participants we just performed density analysis on in the previous Figures. Figures 58 
and 59 illustrate the palpation path color coded with depth values, bright yellow being the 
deepest depressions. It can be clearly seen in Figure 59 that the successful participant’s deepest 
palpation depressions are within close proximity to the fistula; whereas, the unsuccessful 
participant in Figure 58 has multiple deep palpation depressions not adjacent to the fistula. These 
results were expected because it was predicted that skilled participants would utilize palpation 
techniques that required variable force to discern what they are feeling through the skin when 
they encounter a vibratory stimulus or obstruction. In an article detailing the manual palpation of 
hard nodules in soft tissues it was observed that in order to examine a soft environment and 
discover the random hard insertions in an “efficient” manner the participant applies variable 
examination techniques utilizing force modulation. After a hard nodule was discovered within 
the soft tissue, a decrease in stress magnitude was observed.8 There is a positive correlation 
between palpation depression depth, applied force, and stress magnitude.  We did observe that 
the mean palpation depth of successful participants, 407.23 mm, was less than that of the 
unsuccessful participants, 415.39 (Figure 60). We did not observe a reduction in palpation depth 
once the participant began palpating over the fistula; ergo, we did not observe a reduction in 
applied pressure once the participants located the fistula.8 We hypothesized 95 % of palpation 
locations with a depression depth 10 mm below the current trials mean palpation depth would be 
within 60 mm of the fistula midpoint.  Figures 61 and 62 support this hypothesis; they 
demonstrate that unlike in unsuccessful trials, successful participants begin to depress deeper 
into the simulator as they feel increasing vibratory stimulus and something stiff beneath the skin. 
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Figure 63 shows that this trend only very mildly holds true.  Successful participants had an 
average of 13.95 % of their 10 mm deeper palpation locations within 60 mm of the fistula, and 
unsuccessful participants had an average of 11.87 %.  While these results are inconclusive and 
do not coincide with our hypothesis, we believe that our sample population skews our results 
because none of them have prior palpation experience and therefore cannot be held accountable 
for not using variable pressure techniques. Our results do match that of previous studies which 
specify that applied palpation force is statistically insignificant on the rate of hard nodule 
detection.8 For future studies it will be necessary to record trials using experts and novices in 
order to rule in favor or rule out palpation depression as a metric of skill.  Leading in to our next 
metric, palpation velocity, it has been observed that experts utilize force and velocity modulation 
to locate hard inclusions, though for novices only palpation velocity modulation influences the 
degree of detection.8  
Palpation velocity is believed to be a key metric in measuring the skill of the participant.  
The highest detection rate for discovering hard nodules in soft tissue is observed for “slow 
palpation velocity.”8 Figures 64 and 65 are plots of the index finger’s palpation path color coded 
in velocity values (mm/s), blue being the slowest. The unsuccessful participant, Figure 64, is 
palpating relatively slow during the entire trial, but the successful participant, Figure 65, palpates 
quickly away from the fistula and much more slowly when in close proximity to the fistula. The 
mean palpation velocity for unsuccessful participants was 65.90 mm/s and for successful 
participants it was 67.52 mm/s (Figure 66). We hypothesize all palpation locations with 
palpation velocities 20 % slower than the current trial’s mean palpation velocity will be within 
60 mm of the fistula midpoint. It is observed in Figures 67 and 68 that the unsuccessful 
participant has a plethora of palpation locations with a 20 % decrease in velocity away from the 
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fistula; however, the successful participant has the vast majority of his decreased velocity 
locations in close proximity to the fistula.  These findings are further supported by Figure 69 
where it is made very obvious that successful and unsuccessful participants use very different 
velocity modulation techniques. Unsuccessful participants on average only had 24.19 % of their 
20 % slower palpation locations within 60 mm of the fistula midpoint.  In contrast, successful 
participants had an incredible 88.05 % of their 20 % slower velocity palpation locations within 
60 mm of the fistula midpoint. These results fully support our hypothesis, and we expect this 
trend to continue should we take more trials in the future. Decreased velocity in close proximity 
to the fistula is a very useful metric for measuring palpation skill.  
I mentioned before that we “initially” believed a 60 mm radius circle originating from the 
fistula midpoint to be an accurate representation of the dispersion of the fistula’s vibratory 
stimulus. The vibration motor is not a single motor at the fistula midpoint but, in fact, there is a 
vibration motor at each endpoint of the fistula.  For future analysis we believe two 30 mm radius 
circles originating from each of the fistula endpoints to be a more accurate representation of the 
vibratory propagation through the simulator. We believe this will make our results less skewed 
and will still maintain our metrics we have established useful.  
In conclusion, the Leap Motion Controller has proven to be sufficiently accurate for the 
analysis of palpation within the dimensions of our simulator. We have found novel metrics for 
measuring palpation skill and upheld some older metrics that are indicative of proper palpation 
technique. Palpation velocity, density, ratio of palpation location, fistula orientation, and 
percentage of gross versus fine palpation all are metrics that have shown trends in measuring 
palpation skill. For future studies, changing our sample population to a mix of experts and 
novices will be imperative for further discerning which metrics ought to be given the most 
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weight.  The automatic classification of palpation technique via the Leap Motion data is the next 
step for enriching our study.  Palpation is used in just about every clinic and the need to detail a 
standard palpation protocol for which the clinicians to expand upon is of the upmost importance 
for improving quality of care especially within the field of hemodialysis.  
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